date:Feb 20, 2023
s while replicating an umami-rich flavor and meaty texture.
Elo Life Systems completed series A financing, raising a total of US$24.5 million. Existing investors, including AccelR8, Novo Holdings and DCVC Bio, led the financing, enabling Elo Life Systems to accelerate the development of its natural, plant-based sweetener products by advancing US regulatory approvals, building pilot-scale processing capabilities, and market-testing its sweetener with consumers. Elo also expects to open a series